2018 Reed Dynasty Trust sold $1.6M of ARHS

2018 Reed Dynasty Trust sold 127,965 shares of Arhaus, Inc. (ARHS) at an average of $12.63 ($12.02–$13.03, $1.62M total) across 2 trades over 2026-11-03 to 2026-11-04 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · 2018 Reed Dynasty Trust
Published Nov 5, 2026, 10:28 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 5, 2026, 10:33 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ARHS
Bearish
medium confidence
Mentioned
$ARHS
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ARHSBearishLow
01

Why it matters

The disclosed insider sale provides fresh data for traders assessing short‑term pressure on ARHS.

02

Market read

Primary disclosure of an insider sale; modest relevance for short‑term traders.

03

What to watch

Sale executed via pre‑arranged plan, reducing signaling strength.

Relevance 5/10Novelty 4/10Timing: after-hours filing

Background

Arhaus Inc. (ARHS) filed a Form 4 showing a 10% owner sold shares under a 10b5-1 plan.

Company-level read

Ticker impact

$ARHSBearishMedium confidence
Context

Form 4 disclosed a 10% owner sold 127,965 shares for $1.6M via a 10b5-1 plan.

Expected impact

likely modest pressure as the market prices in the insider sell.

Evidence & confidence

The sale size is modest relative to market cap, but insider ownership reduction can weigh on price.

Market effects

Minimal impact on home furnishings sector.

No broader regional effect.

Not globally relevant.

Counterpoint

Insider may be diversifying; sale does not imply company weakness.

Key entities

  • Arhaus, Inc.

    Home furnishings retailer listed on NASDAQ.

  • 2018 Reed Dynasty Trust

    10% owner of ARHS executing a pre‑arranged sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ARHSMedAI 8/10

Arhaus Inc (ARHS) Q3 2026 Earnings Call Highlights: Record Revenue and Surging Written

Arhaus Inc (ARHS) reported Q3 2026 revenue growth but net income declined 36% YoY to $7.8M. Adjusted EBITDA margin contracted 170 bps to 7.4% due to higher SG&A and cost pressures. Gross margin was impacted by fuel surcharges, showroom costs, and channel mix. The company expects elevated fuel and transportation costs to persist. New showroom expansions and pre-opening costs pressured gross margins but are expected to moderate.

$ARHSMedAI 8/10

Arhaus, Inc. Q3 2026 Earnings Call Summary

Arhaus reported strong Q3 2026 earnings, driven by high-end clients and new product introductions. Revenue guidance was raised, with strategic reinvestments in digital commerce and technology. Challenges include supply chain and tariff costs, but management expects improvements in margins and savings from new systems. New customer growth and e-commerce potential were highlighted.

$ARHSMed

What Arhaus (ARHS) Said on Its Q3 Earnings Call

Arhaus reported Q3 gross profit of $144M, up 8.2%, with gross margin expanding to 39.2%. SG&A expenses rose 14.8% to $134.3M. The company raised its full-year revenue outlook to $1.465B-$1.485B but maintained net income and EBITDA forecasts. Arhaus expects to invest in digital initiatives and expand catalog circulation. Cash reserves totaled $318M with no long-term debt.